Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.27B
sum of reported positions
Reported positions
833
Changes vs prior quarter
994
141 new · 267 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 6 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.05M | $146M | 2.3% | |
| 333K | $83.8M | 1.3% | |
| 223K | $76.6M | 1.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.73B | $6.27B |
| Positions | 959 | 833 |
| Biggest line | — | Intel 2% |
| 957K |
| $74.9M |
| 1.2% |
| 403K | $73M | 1.2% |
| 696K | $71.2M | 1.1% |
| 76K | $70.7M | 1.1% |
| 176K | $69.9M | 1.1% |
| 514K | $69.6M | 1.1% |
| 922K | $68.6M | 1.1% |
| 1.66M | $68.6M | 1.1% |
| 65K | $68.2M | 1.1% |
| 396K | $66.5M | 1.1% |
| 680K | $65.3M | 1.0% |
| 236K | $65.1M | 1.0% |
| 409K | $62M | 1.0% |
| 660K | $60.5M | 1.0% |
| 571K | $59.1M | 0.9% |
| 151K | $54.8M | 0.9% |
| 849K | $54.5M | 0.9% |
| 185K | $54.3M | 0.9% |
| 1.57M | $50.2M | 0.8% |
| 642K | $49.9M | 0.8% |
| 176K | $49.9M | 0.8% |
| 268K | $48.2M | 0.8% |
Idt (IDT)
23K → 24K shares (+5%)
Genesco (GCO)
38K → 41K shares (+7%)
California Resources Corporation (CRC)
9,920 → 25K shares (+155%)
Cbl & Associates Properties (CBL)
19K → 25K shares (+32%)
John B. Sanfilippo & Son, Inc. (JBSS)
3,000 → 15K shares (+408%)
Arko (ARKO)
129K → 162K shares (+25%)
Bristow Group Inc. (VTOL)
12K → 31K shares (+163%)
Arbutus Biopharma (ABUS)
19K → 264K shares (+1301%)
Cabaletta Bio (CABA)
18K → 383K shares (+2078%)
Cto Realty Growth (CTO)
49K → 55K shares (+13%)
Anteris Technologies Global (AVR)
66K → 117K shares (+77%)
Bicara Therapeutics (BCAX)
14K → 39K shares (+176%)
Oil-Dri Corp of America (ODC)
6,380 → 11K shares (+75%)
Rocket Pharmaceuticals (RCKT)
261K → 332K shares (+27%)
Unitil Corporation (UTL)
16K → 20K shares (+23%)
Chesapeake Utilities Corp. (CPK)
2,086 → 8,392 shares (+302%)
OneSpaWorld Holdings Limited (OSW)
35K → 36K shares (+4%)
Granite Ridge Resources (GRNT)
14K → 224K shares (+1513%)
CorVel Corporation (CRVL)
6,905 → 15K shares (+117%)
Geopark (GPRK)
16K → 99K shares (+515%)
Ardent Health (ARDT)
43K → 88K shares (+105%)
Infinity Natural Resources (INR)
12K → 67K shares (+451%)
CVR Partners, LP (UAN)
2,133 → 7,539 shares (+253%)
Prothena Corp Public Ltd (PRTA)
68K → 83K shares (+22%)
Kyverna Therapeutics (KYTX)
28K → 89K shares (+219%)